Healthcare Professionals

Online Resources

Contact Us

Sign our Guest Book

 


UROCIT-K
(potassium citrate) wax matrix tablets  

 

Consumer Medicine Information leaflet

Kidney Stones

Stone Prevention Diet

What is ESWL?

Press Release

If you've ever suffered from a kidney stone attack you will probably do anything in your power to prevent a recurrence. Now there's a specific preventative medical treatment that can greatly reduce the likelihood of your having another stone attack.

How does Urocit-K work?
The potassium citrate in Urocit-K works partly by restoring the natural occuring chemicals that block the formation of stones. By normalising the urinary environment, calcium stones and crystal formation are inhibited.

Urocit-K also reduces the tendency of uric acid to form stones. Most patients with this type of stone, when treated with Urocit-K did not form stones at all. In those who still formed stones, the stones developed at a lower rate than before treatment.

Urocit-K and the Unique Wax Matrix System
Urocit-K is the only potassium citrate medication approved for the treatment of calcium and uric acid stones. It's also unique as it contains potassium citrate in a wax matrix tablet. This wax matrix system delivers a slow, sustained release of medication which allows for convenient twice-a-day dosing....once in the morning, and once at night. The slow release tablets also caused less gastrointestinal upsets.


Return to Product List

Orphan Australia Pty Ltd. 48 Kangan Drive, Berwick Victoria, 3806 Australia
Telephone : 61 3 9769 5744
----- Facsimile : 61 3 9769 5944 ----- Email : info@orphan.com.au

A member of the Sigma group of companies

Company | Product | Professionals | Related Links | Contact | Home